Martin Tolstrup

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann et al. · The Lancet HIV · 2014 · 629 citations

Histone Deacetylase Inhibitor, Treatment And Prevention, Neurovirology +10

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Ole S. Søgaard, Mette E. Graversen, Steffen Leth et al. · PLoS Pathogens · 2015 · 514 citations · Full text

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 192 citations · Full text

Controlled Trial, Covid-19 Pandemic, Clinical Trials +6

Comparison of HDAC inhibitors in clinical development

Thomas A. Rasmussen, Ole S. Søgaard, Christel R. Brinkmann et al. · Human Vaccines & Immunotherapeutics · 2013 · 189 citations · Full text

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Steffen Leth, Mariane Høgsbjerg Schleimann, Sara Konstantin Nissen et al. · The Lancet HIV · 2016 · 173 citations

Vaccination, Granulocyte, Human Retrovirus +9